Participate in Cutting-Edge Clinical Trials for COPD and Lung Diseases
Join our clinical trials and access state-of-the-art treatments while helping us advance the understanding and treatment of COPD, Bronchiectasis, Chronic Cough, and Asthma. Dr. Frank Hull and our research team are continuously working on new trials to improve patient care and treatment options.
Our asthma studies focus on new biologics for severe asthma, novel inhaler combinations, and reducing exacerbation frequency.
Learn more about Asthma researchCOPD research includes novel anti-inflammatory approaches, treatments to reduce flare-ups, and studies examining if COPD control reduces cardiac events.
Learn more about COPD researchOur bronchiectasis studies focus on preventing exacerbations, reducing the need for rescue antibiotics, and stopping further airway damage.
Learn more about Bronchiectasis researchChronic cough research investigates novel nerve-targeting medications and therapies to improve quality of life for those with persistent cough.
Learn more about Chronic Cough researchJoin our ongoing research studies and gain access to innovative treatments while contributing to medical advancement.
Comparing BREZTRI vs BEVESPI to examine if optimized COPD treatment can reduce cardiac events like MI and stroke.
Testing camplipixant, a P2X3 inhibitor for neuropathic cough that has persisted for more than one year.
Investigating a novel treatment approach for non-cystic fibrosis bronchiectasis patients with frequent exacerbations.
Testing tozorakimab (IL-33 antibody) for patients with COPD who experience frequent exacerbations despite standard therapy.
Receive comprehensive health assessments, advanced diagnostic testing, and regular monitoring by our specialized team.
Gain access to innovative treatments not yet widely available, completely free of charge during the study period.
Receive transportation assistance, flexible scheduling, and ongoing support throughout your participation.
Help develop new treatments that may benefit millions of future patients with respiratory conditions.
Dr. Frank Hull is a board-certified pulmonologist with decades of experience in managing COPD and other respiratory conditions. He leads the clinical trial program at Broward Pulmonary and Sleep Specialists, dedicated to advancing patient care through research and innovation.
Our clinic is committed to providing comprehensive and compassionate care, offering access to cutting-edge treatments and clinical trials. We work closely with patients and their primary care physicians to ensure coordinated and effective care.
Contact our research team today to learn about participation opportunities and find out if you qualify.
Broward Pulmonary and Sleep Specialists
10059 NW 1st Court
Plantation, FL 33324
General Contact:
Phone: 954-522-7226 x1
Fax: 954-522-1840
Research/Clinical Trial Referrals:
Research Referral Line: 954-520-7296 x1 (to Edric Caampued PA)
Research Referral Fax: 954-523-8569
Email:
